![Utilizing clinical research organization for late phase I studies](https://www.georgeclinical.com/wp-content/uploads/2016/10/Utilizing-clinical-research-organization-for-late-phase-I-studies-300x300.jpg)
Utilizing Clinical Research Organizations for late Phase I studies
A key step in developing a new drug is the transition from the laboratory to the human subject in a Phase I clinical trial, where the new compound is given to humans for the first time. A Phase I trial is the gateway between scientific research and clinical medicine. Generally, in-human Phase I studies are […]
Read More